These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3079799)

  • 1. DNA of human Raji target cells is damaged upon lymphocyte-mediated lysis.
    Gromkowski SH; Brown TC; Cerutti PA; Cerottini JC
    J Immunol; 1986 Feb; 136(3):752-6. PubMed ID: 3079799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
    Bonavida B; Katz J
    J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.
    Maryanski JL; Accolla RS; Jordan B
    J Immunol; 1986 Jun; 136(12):4340-7. PubMed ID: 3086429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for CD28-dependent T cell-mediated cytotoxicity.
    Azuma M; Cayabyab M; Phillips JH; Lanier LL
    J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA fragmentation induced by cytotoxic T lymphocytes can result in target cell death.
    Helgason CD; Shi L; Greenberg AH; Shi Y; Bromley P; Cotter TG; Green DR; Bleackley RC
    Exp Cell Res; 1993 Jun; 206(2):302-10. PubMed ID: 8500550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes. II. Comparison with polymorphonuclear leukocytes against erythrocyte and nucleated target cells.
    Fuson EW; Shaw MW; Hubbard RA; Sugantharaj DG; Lamon EW
    Exp Hematol; 1981 Feb; 9(2):197-206. PubMed ID: 7238651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic lymphocyte-derived lytic granules do not induce DNA fragmentation in target cells.
    Duke RC; Sellins KS; Cohen JJ
    J Immunol; 1988 Oct; 141(7):2191-4. PubMed ID: 2844898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of DNA degradation in target cells lysed by granules derived from cytolytic T lymphocytes.
    Gromkowski SH; Brown TC; Masson D; Tschopp J
    J Immunol; 1988 Aug; 141(3):774-8. PubMed ID: 3260910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degree of CTL-induced DNA solubilization is not determined by the human vs mouse origin of the target cell.
    Howell DM; Martz E
    J Immunol; 1987 Jun; 138(11):3695-8. PubMed ID: 3495567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell growth-dependent variation in the sensitivity of human and mouse tumor cells to complement-mediated killing.
    Ohanian SH; Yamazaki M; Schlager SI; Faibisch M
    Cancer Res; 1983 Feb; 43(2):491-5. PubMed ID: 6401218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity.
    Stalder T; Hahn S; Erb P
    J Immunol; 1994 Feb; 152(3):1127-33. PubMed ID: 7507960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrest of the cell cycle reduces susceptibility of target cells to perforin-mediated lysis.
    De Leon M; Jackson KM; Cavanaugh JR; Mbangkollo D; Verret CR
    J Cell Biochem; 1998 Jun; 69(4):425-35. PubMed ID: 9620169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. III. Species specificity of lymphocyte target cell recognition in vitro.
    Stejskal V; Perlmann P
    Eur J Immunol; 1976 May; 6(5):347-52. PubMed ID: 991906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.